Log in to save to my catalogue

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue thera...

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue thera...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e859b7788aa4f928909ae41cd4332af

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data

About this item

Full title

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data

Publisher

England: BioMed Central Ltd

Journal title

BMC infectious diseases, 2017-09, Vol.17 (1), p.658-7, Article 658

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Dolutegravir (DTG) plus darunavir/ritonavir (DRV/r) is a simple combination of drugs that has the best genetic barrier to HIV-1 resistance and may be fit for salvage therapy.
All HIV-1-infected subjects treated with DTG plus DRV/r between March 2014 and September 2015 in eight Italian centres were included in the analysis. The main metabolic dat...

Alternative Titles

Full title

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1e859b7788aa4f928909ae41cd4332af

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e859b7788aa4f928909ae41cd4332af

Other Identifiers

ISSN

1471-2334

E-ISSN

1471-2334

DOI

10.1186/s12879-017-2755-4

How to access this item